MAOB and Alzheimer disease: Some MAO-B inhibitors have been evaluated in clinical trials for the treatment of AD (e.g., Rasagiline, Lazabemide, Safinamide, and Selegiline, and these have shown positive effects on memory patterns and progression of disease [10,17,18,19].